The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The prognostic value of peripheral blood inflammatory indices early variation in patients (pts) with metastatic renal cell carcinoma (mRCC) treated with nivolumab (Δ-Meet-URO analysis).
 
Sara Elena Rebuzzi
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb
Speakers' Bureau - Bristol-Myers Squibb; GlaxoSmithKline
Travel, Accommodations, Expenses - Bristol-Myers Squibb; MSD
 
Alessio Signori
No Relationships to Disclose
 
Sebastiano Buti
Consulting or Advisory Role - BMS; Ipsen; MSD; Novartis; Pfizer
Speakers' Bureau - BMS; Ipsen; MSD; Novartis; Pfizer
Research Funding - Novartis (Inst)
 
Giuseppe Luigi L. Banna
Consulting or Advisory Role - Astellas Pharma; AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca/MedImmune
 
Marco Stellato
No Relationships to Disclose
 
Daniele Santini
No Relationships to Disclose
 
Umberto Basso
Consulting or Advisory Role - Bristol-Myers Squibb
Research Funding - Ipsen
Other Relationship - Bristol-Myers Squibb; Ipsen
 
Ugo De Giorgi
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Clovis Oncology; Dompé Farmaceutici; Eisai; Ipsen; Janssen; Merck; MSD; Novartis; Pfizer; PharmaMar
Research Funding - AstraZeneca (Inst); Roche (Inst); Sanofi (Inst)
Travel, Accommodations, Expenses - Ipsen; Pfizer
 
Silvia Chiellino
No Relationships to Disclose
 
Alessia Salfi
No Relationships to Disclose
 
Paolo Andrea Zucali
Consulting or Advisory Role - Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; Merck Sharp & Dohme; Novartis; Pfizer; Roche; Sanofi
Speakers' Bureau - Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; Merck Sharp & Dohme; Novartis; Pfizer; Roche; Sanofi
Travel, Accommodations, Expenses - Amgen; Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Ipsen; Janssen; Merck Sharp & Dohme; Novartis; Pfizer; Roche; Sanofi
 
Cristina Masini
Consulting or Advisory Role - Astellas Pharma; Ipsen; Janssen; MSD
Travel, Accommodations, Expenses - Ipsen
 
Emanuele Naglieri
No Relationships to Disclose
 
Giuseppe Procopio
Consulting or Advisory Role - Astellas Pharma; Bayer; Bristol-Myers Squibb (BMS); Ipsen; Janssen; Merck Sharp & Dohme; Novartis; Pfizer
 
Michele Milella
Honoraria - AstraZeneca; Boehringer Ingelheim; EUSA Pharma; Ipsen; MSD; Pfizer; Roche
Consulting or Advisory Role - Novartis
Research Funding - Roche (Inst)
 
Francesco Boccardo
No Relationships to Disclose
 
Lucia Fratino
No Relationships to Disclose
 
Stefania Pipitone
No Relationships to Disclose
 
Camillo Porta
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squibb; Eisai; EUSA Pharma; Ipsen; Merck Serono; MSD Oncology; Novartis; Pfizer
Speakers' Bureau - Angelini; AstraZeneca; Bristol-Myers Squibb; Eisai; EUSA Pharma; General Electric; Ipsen; Merck Serono; Merck Serono; MSD Oncology; Pfizer
Expert Testimony - EUSA Pharma; Pfizer
Travel, Accommodations, Expenses - Roche
 
Giuseppe Fornarini
Honoraria - Bristol-Myers Squibb; Ipsen; Janssen; MSD; Novartis; Pfizer; Sanofi
Consulting or Advisory Role - Bristol-Myers Squibb; Ipsen; Janssen; MSD; Novartis; Pfizer; Sanofi
Research Funding - Roche (Inst)